Loading...
Loading...
Browse all stories on DeepNewz
VisitMedicare to Cap Prescription Drug Costs at $2,000 Annually for 19 Million, Saving $400 on Average
Dec 31, 2024, 07:38 PM
Starting January 1, 2025, Medicare beneficiaries will benefit from a new $2,000 annual cap on out-of-pocket costs for prescription drugs under Part D, as mandated by the Inflation Reduction Act of 2022. This cap is expected to save millions of Americans money on their medications, with an estimated 19 million seniors and people with disabilities saving an average of $400 per year. The legislation also includes other cost-saving measures such as a $35 monthly cap on insulin prescriptions, no-cost vaccines, and Medicare's ability to negotiate drug prices. Prior to this law, there was no cap on out-of-pocket costs for medications covered by Part D plans, leaving enrollees responsible for 5% of their drugs' cost in the catastrophic coverage phase, which began at $7,400 in 2023. An interim cap of $3,500 was in place for 2024. This new provision does not apply to medications administered in doctors' offices, such as certain chemotherapy or infusions covered by Medicare Part B.
View original story
More than 30 • 25%
Less than 10 • 25%
10 to 20 • 25%
21 to 30 • 25%
4-6 Countries • 25%
None • 25%
1-3 Countries • 25%
More than 6 Countries • 25%
1-5 million • 25%
Less than 1 million • 25%
More than 10 million • 25%
5-10 million • 25%
Less than 10,000 • 25%
50,001 to 100,000 • 25%
10,000 to 50,000 • 25%
More than 100,000 • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
More than 5 million • 25%
Less than 1 million • 25%
3 to 5 million • 25%
1 to 3 million • 25%
No countries • 25%
More than 10 countries • 25%
6 to 10 countries • 25%
1 to 5 countries • 25%
3-5 million doses distributed • 25%
0-1 million doses distributed • 25%
1-3 million doses distributed • 25%
Over 5 million doses distributed • 25%
8-11 Vaccines • 25%
4-7 Vaccines • 25%
0-3 Vaccines • 25%
12-14 Vaccines • 25%
Less than 10,000 • 25%
More than 100,000 • 25%
50,001 to 100,000 • 25%
10,000 to 50,000 • 25%
3-4 • 25%
None • 25%
1-2 • 25%
5 or more • 25%
Less than 10,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
10,000 to 50,000 • 25%
Other • 25%
Cancer treatments • 25%
Cardiovascular drugs • 25%
Diabetes medications • 25%